The role of cd90 in the differential diagnosis of pleural malignant mesothelioma pulmonary carcinoma and comparison with calretının

Basit Öğe Kaydı
dc.authorid1257en_US
dc.authorid204609en_US
dc.authorid107963en_US
dc.contributor.authorŞahin, Nurhan
dc.contributor.authorAkatlı, Ayşe Nur
dc.contributor.authorÇelik, Muhammet Reha
dc.contributor.authorUlutaş, Hakkı
dc.contributor.authorSamdancı, Emine Türkmen
dc.date.accessioned2017-12-15T12:51:04Z
dc.date.available2017-12-15T12:51:04Z
dc.date.issued2016
dc.departmentİnönü Üniversitesien_US
dc.descriptionPathol. Oncol. Res. (2017) 23:487–49.en_US
dc.description.abstractAbstract Pleural Malignant Mesothelioma (MM) is a fatal disease that has been associated with asbestos exposure. Differential diagnosis between the pleural infiltration of pulmonary carcinomas and MM is rather difficult particularly for epitheloid type mesothelioma.We aimed to investigate the utility of CD90, a cancer stem cell marker, in the differential diagnosis of MM and lung carcinoma, its prognostic significance and compare its value with that of Calretinin. Ninety pathology specimens including MM (n:30), pulmonary adenocarcinoma (n:30) and pulmonary squamous cell carcinoma (n:30) were used in this study. Immunohistochemical comparision of CD 90 and Calretinin was made in all groups. Calretinin was positive in 20 cases with MM (64.5 %), and was negative in 10 (32.3 %). CD 90 was positive in 25 of these cases (80 %) and negative in 5 (16 %). On the other hand pulmonary adenocarcinomas and squamous cell carcinomas showed positivity with CD90, 63,6 % and 73 %, respectively. We think that CD 90 has no place in the differential diagnosis between mesothelioma and pulmonary carcinoma because of the low specificity in spite of the high sensitivity.en_US
dc.identifier.citationŞahin, N., Akatlı, A. N., Çelik, M. R., Ulutaş, H., Şamdancı, E., & Çolak, C. (2016). The Role Of Cd90 İn The Differential Diagnosis Of Pleural Malignant Mesothelioma Pulmonary Carcinoma And Comparison With Calretının. Pathology & Oncology Research, 1–5.en_US
dc.identifier.doi10.1007/s12253-016-0135-9en_US
dc.identifier.endpage0en_US
dc.identifier.issue0en_US
dc.identifier.startpage0en_US
dc.identifier.urihttps://link.springer.com/content/pdf/10.1007%2Fs12253-016-0135-9.pdf
dc.identifier.urihttps://hdl.handle.net/11616/7895
dc.identifier.volume0en_US
dc.language.isoenen_US
dc.publisherPathology & Oncology Researchen_US
dc.relation.ispartofPathology & Oncology Researchen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMesotheliomaen_US
dc.subjectCD 90en_US
dc.subjectPulmonary adenocarcinomaen_US
dc.subjectSquamous cell carcinomaen_US
dc.titleThe role of cd90 in the differential diagnosis of pleural malignant mesothelioma pulmonary carcinoma and comparison with calretınınen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Makale Dosyası.pdf
Boyut:
4.28 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Tıp Fakültesi, Biyoistatistik ve Tıp Bilişimi Anabilim Dalı Koleksiyonu